Indian Pharmaceutical Market Outlook - Enhanced purchasing power, rural market penetration and expandedaccess to healthcar...
Develop market-entry and market-expansion strategies by identifying the leading segments poised for stronggrowth Device a ...
4.2.6 Drugs And Cosmetics Act (amendment) 2008 274.3 Drug Distribution Structure 284.4 National Pharmaceuticals Pricing Po...
6.3.3 Outlook 506.4 Gastrointestinal 516.4.1 Market Size 516.4.2 Recent Developments 526.4.3 Outlook 526.5 Diabetes 536.5....
7.6 Patented Products Introduced In Niche Segments 727.6.1 Case Study - Mercks Successful Strategy For Patented Products 7...
10.4.1 Coverage 9310.4.2 Secondary Research 9310.4.3 Primary Research 9310.4.4 Expert Panel Validation 9410.5 Contact Us 9...
Upcoming SlideShare
Loading in...5
×

Indian Pharmaceutical Market Outlook Available on Researchmoz.us

289

Published on

Indian Pharmaceutical Market Outlook Enhanced purchasing power, rural market penetration and expanded access to healthcare attracting Big Pharma investment provides in-depth analysis of the trends, issues and challenges facing the Indian pharmaceutical market. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts. The Indian pharmaceutical industry grew from $0.8 billion in 1980 to $21.73 billion in 2010 and is expected to grow further as Multinational Companies (MNCs) enter the market. Although pharmaceutical giants such as GlaxoSmithKline (GSK) have been present in the market for years, the rising income of the middle-class population, changing patent laws, low-cost skilled labor and low-priced infrastructure in India have attracted other MNCs. With the current scenario, the market is expected to grow at a Compound Annual Growth Rate (CAGR) of 12% during the 20112015 period. Branded generics are expected to become more prevalent in India as many global players are planning to launch them after their patents expire.

Published in: Business, News & Politics
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
289
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Indian Pharmaceutical Market Outlook Available on Researchmoz.us

  1. 1. Indian Pharmaceutical Market Outlook - Enhanced purchasing power, rural market penetration and expandedaccess to healthcare attracting Big Pharma investment Indian Pharmaceutical Market Outlook Enhanced purchasing power, rural market penetration and expandedaccess to healthcare attracting Big Pharma investment Summary GBI Researchs new report Indian Pharmaceutical Market Outlook Enhanced purchasing power, rural marketpenetration and expanded access to healthcare attracting Big Pharma investment provides in-depth analysis ofthe trends, issues and challenges facing the Indian pharmaceutical market. It is built using data andinformation sourced from proprietary databases, primary and secondary research and in-house analysis by GBIResearchs team of industry experts. The Indian pharmaceutical industry grew from $0.8 billion in 1980 to$21.73 billion in 2010 and is expected to grow further as Multinational Companies (MNCs) enter the market.Although pharmaceutical giants such as GlaxoSmithKline (GSK) have been present in the market for years,the rising income of the middle-class population, changing patent laws, low-cost skilled labor and low-pricedinfrastructure in India have attracted other MNCs. With the current scenario, the market is expected to grow ata Compound Annual Growth Rate (CAGR) of 12% during the 20112015 period. Branded generics areexpected to become more prevalent in India as many global players are planning to launch them after theirpatents expire. The once highly fragmented Indian pharmaceutical industry is undergoing strategic consolidations with theaim of emerging as a highly organized sector. With the inflow of MNCs R&D operations the industry willcontinue to experience a trend of M&A. Deals and acquisitions are set to continue due to low-costinfrastructure and labor as patent expiries and the thin pipelines of major companies will cause revenues tofall. The Indian government has implemented various initiatives to increase insurance coverage and reducehealthcare costs, such as the National Rural Health Mission and Jan Aushadhi. A revised pricing policy wasalso proposed in 2011, which will increase government control to over 60% of drugs. Rising income levels, changing disease patterns, increasing reach of healthcare, reduced out-of-pocketexpenditure and growth of new products such as generics and biosimilars are expected to drive growth in thefuture. Scope Macroeconomic environment of the pharmaceutical industry in India, covering demographic analysis,drivers, and barriers Important industry characteristics, looking at healthcare policies, regulations, distribution,pricing, taxation, spending, insurance and reimbursement Market analysis of segments such as prescriptionmedicines, biotechnology, over-the-counter medicines and Contract Research and Manufacturing Services(CRAMS) Annualized market data from 2005 to 2010 for important therapeutic segments Competitiveprofiling of five major domestic and international companies operating in the Indian pharmaceutical marketAnalysis of licensing, partnership and M&A deals that took place between 2007 and 2011 Reasons to buyIndian Pharmaceutical Market Outlook - Enhanced purchasing power, rural market penetration and expanded access to healthcare attracting B
  2. 2. Develop market-entry and market-expansion strategies by identifying the leading segments poised for stronggrowth Device a more tailored country strategy through understanding key drivers of and barriers to thepharmaceutical market Develop key strategic initiatives by understanding leading companies key focus areasAccelerate and strengthen your market position by identifying key companies for M&A and strategicpartnershipstable Of Contents 1 Table Of Contents1 Table Of Contents 51.1 List Of Tables 81.2 List Of Figures 92 Indian Pharmaceutical Market Outlook Introduction 10 3 Indian Pharmaceutical Market Outlook Overview 113.1 Global Pharmaceutical Industry Landscape 113.2 Macro View Of The Indian Pharmaceutical Sector 123.3 Demographic Analysis 133.3.1 Population Size, Growth, And Structure 133.3.2 Crude Death Rate 153.3.3 Infant Mortality Rate 163.3.4 Life Expectancy At Birth 173.4 Driver And Barriers 193.4.1 Drivers 193.4.2 Barriers 213.5 Swot Analysis Of Indian Pharmaceutical Industry 22 4 Indian Pharmaceutical Market Outlook Industry Characteristics 234.1 Healthcare Policy 234.1.1 National Health Policy 2002 234.1.2 National Rural Health Mission 234.1.3 National Urban Health Mission 244.2 Intellectual Property Rights In India 254.2.1 Effect Of Patent Laws On Pharmaceutical Production In India 264.2.2 Key Impact Of The New Patent Laws On India 274.2.3 Patent Act 2005 First Step Towards Improving Ip Protection 274.2.4 Ipr Enforcement Rules 2007 274.2.5 Trademarks Bill 2007 27Indian Pharmaceutical Market Outlook - Enhanced purchasing power, rural market penetration and expanded access to healthcare attracting B
  3. 3. 4.2.6 Drugs And Cosmetics Act (amendment) 2008 274.3 Drug Distribution Structure 284.4 National Pharmaceuticals Pricing Policy 294.4.1 Objectives Of The Present Policy 294.4.2 Key Principles Of National Pharmaceuticals Pricing Policy, 2011 294.4.3 Principles For Drug Price Control And Determination In National Pharmaceutical Pricing Policy 2011304.4.4 Other Aspects Of The Policy 304.4.5 Impact Analysis Of The Policy 314.5 Goods And Services Tax 314.5.1 An Introduction To Goods And Services Tax 314.5.2 Dual Goods And Services Tax In India 314.5.3 Impact On The Pharmaceutical Industry 324.6 Direct Tax Code 334.6.1 Tax Structure 334.6.2 Incentives Available To The Pharmaceutical Sector 334.6.3 Road Ahead 334.7 Healthcare Spending In India 344.8 Insurance And Reimbursement 354.8.1 Private Health Insurance 354.8.2 Health Insurance Companies Landscape 36 5 Indian Pharmaceutical Market Outlook Market Analysis 375.1 Market Overview 375.1.1 Contract Research And Manufacturing Services 375.1.2 Biotech 385.1.3 Over-the-counter Drugs 425.1.4 Prescription Drugs 425.1.5 Herbal Medicines 435.2 Market Segmentation 44 6 Indian Pharmaceutical Market Outlook Market Analysis By Therapeutic Categories 466.1 Market Share Of Leading Therapeutic Segment 466.2 Anti-infectives 476.2.1 Market Size 476.2.2 Key Brands And Players 486.2.3 Recent Developments 486.2.4 Outlook 486.3 Cardiovascular System 496.3.1 Market Size 496.3.2 Recent Developments 50Indian Pharmaceutical Market Outlook - Enhanced purchasing power, rural market penetration and expanded access to healthcare attracting B
  4. 4. 6.3.3 Outlook 506.4 Gastrointestinal 516.4.1 Market Size 516.4.2 Recent Developments 526.4.3 Outlook 526.5 Diabetes 536.5.1 Market Size 536.5.2 Recent Developments 546.5.3 Outlook 546.6 Central Nervous System 556.6.1 Market Size 556.6.2 Recent Developments 566.6.3 Outlook 566.7 Respiratory 576.7.1 Market Size 576.7.2 Recent Developments 586.7.3 Outlook 586.8 Dermatology 596.8.1 Market Size 596.8.2 Recent Developments 606.8.3 Outlook 606.9 Oncology 616.9.1 Market Size 616.9.2 Recent Developments 626.9.3 Outlook 62 7 Indian Pharmaceutical Market Outlook Key Trends 637.1 Rapid Consolidation And Rise Of Multinational Corporations In The Indian Pharmaceutical Industry 637.1.1 M&a Deals 637.1.2 Licensing Deals 657.1.3 Partnership Deals 667.2 Patent Litigations Favoring Generics 677.2.1 Indian Patent Office Revokes Patent For Pfizers Cancer Drug Sutent (sunitinib) 677.2.2 Indian Appeals Body Dismisses Bayers Plea For Stay On Natcos Generic Nexavar (sorafenib) 677.2.3 Delhi High Court Rules In Favor Of Cipla In Roches Tarceva (erlotinib) Patent Lawsuit 677.2.4 Indian Supreme Court Asks Novartis To Scale Down Price Of Cancer Drug Glivec (imatinib) 677.3 Increasing Importance Of Rural Marketing In India 687.3.1 Case Study - Novartis Arogya Parivar Case Study 687.4 Product Localization And India-specific Pricing 707.4.1 Case Study - Glaxosmithkline, Localized Business Model 707.5 Sales Strategies 717.5.1 Case Study - Mankind, Sales Excellence 71Indian Pharmaceutical Market Outlook - Enhanced purchasing power, rural market penetration and expanded access to healthcare attracting B
  5. 5. 7.6 Patented Products Introduced In Niche Segments 727.6.1 Case Study - Mercks Successful Strategy For Patented Products 727.7 Actions Taken By Indian Government Against Counterfeit Drugs 73 8 Indian Pharmaceutical Market Outlook Competitive Landscape 748.1 Key Foreign Companies 748.1.1 Sanofi 748.1.2 Roche 748.1.3 Astrazeneca 758.1.4 Glaxosmithkline 758.1.5 Abbott Laboratories 758.2 Key Domestic Companies 768.2.1 Dr. Reddys Laboratories 768.2.2 Lupin 788.2.3 Cipla Limited 808.2.4 Ranbaxy Laboratories Limited 818.2.5 Biocon 83 9 Indian Pharmaceutical Market Outlook The Way Forward 859.1 Outlook For The Indian Pharmaceutical Industry 859.2 Risks 869.2.1 Currency Fluctuation And Financial Problems Will Make It Difficult To Sustain Growth 869.2.2 Regulatory Hurdles 869.2.3 Financial Disparity 869.2.4 Intellectual Property Concerns 869.3 Recommendations 879.3.1 Improved Links Between Industry And Academia 879.3.2 Focus On R&d Initiatives And Skilled Manpower 879.3.3 Support For Clinical Trials Sector 879.3.4 Quality Drugs To Be Made Affordable And Accessible 879.4 Opportunities Ahead 889.5 Strategies For Future Success 889.5.1 Increasing Importance Of Biosimilars 889.5.2 Rural Markets 89 10 Indian Pharmaceutical Market Outlook Appendix 9010.1 Market Definitions 9010.2 Abbreviations 9010.3 Bibliography 9210.4 Research Methodology 93Indian Pharmaceutical Market Outlook - Enhanced purchasing power, rural market penetration and expanded access to healthcare attracting B
  6. 6. 10.4.1 Coverage 9310.4.2 Secondary Research 9310.4.3 Primary Research 9310.4.4 Expert Panel Validation 9410.5 Contact Us 9410.6 Disclaimer 94About Us:Transparency Market Research is a market intelligence company providing global business informationreports and services. Our exclusive blend of quantitative forecasting and trends analysis providesforward-looking insight for thousands of decision makers. We are privileged with highly experienced team ofAnalysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques togather, and analyze information. Our business offerings represent the latest and the most reliable informationindispensable for businesses to sustain a competitive edge.Contact:ResearchMoz90 State Street,Suite 700,Albany NY - 12207United StatesTel: +1-518-618-1030USA - Canada Toll Free 866-997-4948Email: sales@researchmoz.usBlog: http://researchmoz.blogspot.com/Website: http://www.researchmoz.us/Indian Pharmaceutical Market Outlook - Enhanced purchasing power, rural market penetration and expanded access to healthcare attracting B

×